Private Equity & Venture Capital - Page 1 | TalkMarkets


All Posts > Content under Private Equity & Venture Capital
1 to 16 of 610 Posts
1 2 3 ... 39
Are Private Equity Valuations Too High?
Article By: AllAboutAlpha
Sunday, May 14, 2023 3:51 AM EDT
Some investors are concerned that private equity valuations are too high. The Dow fell 8.8% in 2022, while the S&P 500 and the MSCI World each fell around 18%.
In this article: STEP
KKR Invests $800 Million In Clean Energy Push
Article By: ESG Today
Sunday, May 7, 2023 8:19 PM EDT
Global alternative asset and private equity investor KKR announced allocations of $800 million in renewable energy deals, including with SunPower, and a $250 million investment in India-based industrial decarbonization platform Serentica.
In this article: KKR, SPWR
Why Taiwan Matters - From TSMC To Other Multinational Companies
Article By: EqualOcean
Sunday, May 7, 2023 4:47 PM EDT
As an export-oriented island economy, Taiwan’s advanced economy is inseparable from super-global enterprises like TSMC. Now several other companies are poised to join them on the global stage.
In this article: TSM, EWT
How An Entrepreneur's Gender Impacts Venture Capital Financing & Exit Routes
Article By: R. Isil Yavuz
Thursday, April 27, 2023 3:07 PM EDT
Prior research has explored the influence of a founder’s gender on their motivations and how they operate, but few studies have explored how gender impacts exit routes, including IPOs and M&As.
How VC Funding Is Shifting From Crypto To AI
Article By: The Tokenist
Wednesday, April 26, 2023 3:02 AM EDT
AI has become the latest buzzword in the tech world, largely thanks to the exploding popularity of generative AI chatbots.
Tiktok Service Provider Didadog Raises Millions In Pre-A Round Financing
Article By: EqualOcean
Sunday, April 23, 2023 11:05 AM EDT
On April 20, Chinese TikTok e-commerce data services platform DidaDog
Biogen Moves Deeper In Alzheimer's With Denali
Article By: Bio Deep Dives
Friday, April 14, 2023 9:40 PM EDT
Biogen exercised their rights to a Denali Alzheimer's drug. What does this mean longer term to the field and the companies?
In this article: DNLI, BIIB
Commodities Rock As Banks Look Out Below
Video By: TheoTrade
Monday, April 3, 2023 5:23 PM EDT
OPEC news over the weekend caused oil to soar into backwardation today on significant option activity.
In this video: KGC, MRO, OXY, XOM, AGI, OIL, SLV, USO, XLE, XOP, SPY
The Real Threat Of TikTok
Video By: Shelly Palmer
Wednesday, March 29, 2023 6:34 PM EDT
TikTok is the most addictive social media app ever created.
Will TikTok Be Banned?
Article By: Invezz
Friday, March 24, 2023 2:48 PM EDT
TikTok has about 150 million active users in the United States.
Squirrel In The Matrix
Article By: BlindSquirrelMacro
Sunday, March 19, 2023 8:18 PM EDT
The Blind Squirrel's weekly notes for March 20th, 2023.
In this article: PRX, EDV, EUFN, QQQ, SHY, TLT
Looking Ahead At The PE Landscape With Quantitative Data From 2022
Article By: AllAboutAlpha
Sunday, February 19, 2023 10:30 AM EDT
Last year was a mixed bag for the US private equity market. Deal activity remained resilient even as investors grappled with the deceleration of economic growth and the Federal Reserve's aggressive rate hikes.
NeurAxis: Should You Buy This IPO?
Article By: Avisol Capital Partners
Wednesday, February 8, 2023 12:14 PM EDT
As NeurAxis is ready to launch its IPO, we take a closer look to see if investors should be buying into the hype.
In this article: NRXS Also: MASI, BMY, PFE, ARNA, AMGN, GILD, ABBV, TAK
NeurAxis IPO Sets Stage To Take On Irritable Bowel Syndrome With A Non-Surgical Solution
Article By: Moon Kil Woong
Monday, February 6, 2023 4:14 PM EDT
As NeurAxis gears up for its upcoming IPO, we take a deep dive into the company to see if it's worth adding to your investment portfolio.
In this article: NRXS Also: ABBV, BMY, AMGN, ARNA, GILD, PFE, TAK
How Will AI Change Our Lives?
Article By: Tyler Durden
Sunday, February 5, 2023 2:20 AM EDT
Does ChatGPT mark a watershed moment for AI?
In this article: MSFT, GOOGL
Grayscale’s Legal Woes Worsen As Osprey Sues For “False And Misleading” Claims
Article By: The Tokenist
Tuesday, January 31, 2023 8:01 AM EDT
After offering to replace Grayscale as the manager of GBTC, Osprey is now suing the firm over “false and misleading statements” about the fund's conversion into an ETF.
In this article: GBTC
1 to 16 of 610 Posts
1 2 3 ... 39